Stockscreener 앱 받기
20.47
1.06%
-0.22
시간 외 거래:
19.98
-0.49
-2.39%
Apellis Pharmaceuticals Inc 주식(APLS)의 최신 뉴스
Price-Driven Insight from (APLS) for Rule-Based Strategy - news.stocktradersdaily.com
21,011 Shares in Apellis Pharmaceuticals, Inc. $APLS Bought by Corton Capital Inc. - MarketBeat
Can Apellis Pharmaceuticals Inc. stock resist sector downturnsWeekly Trend Report & Safe Capital Growth Stock Tips - newser.com
How moving averages guide Apellis Pharmaceuticals Inc. trading2025 Stock Rankings & Real-Time Chart Pattern Alerts - newser.com
Will Apellis Pharmaceuticals Inc. see short term momentumTrade Performance Summary & Target Return Focused Stock Picks - newser.com
Apellis Pharmaceuticals (APLS): Mizuho Adjusts Price Target and Rating Update | APLS Stock News - GuruFocus
Risk vs reward if holding onto Apellis Pharmaceuticals Inc.Portfolio Value Report & Safe Swing Trade Setups - newser.com
Using AI based signals to follow Apellis Pharmaceuticals Inc.July 2025 Decliners & Smart Money Movement Alerts - newser.com
Real time scanner hits for Apellis Pharmaceuticals Inc. explainedJuly 2025 Market Mood & Safe Entry Trade Reports - newser.com
Is Apellis Pharmaceuticals Inc. stock attractive for income investorsWeekly Market Summary & Expert Approved Momentum Ideas - newser.com
Why Apellis Pharmaceuticals Inc. (1JK) stock could rally stronglyMarket Movement Recap & AI Driven Stock Price Forecasts - newser.com
Will breakout in Apellis Pharmaceuticals Inc. lead to full recoveryJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - newser.com
Will a bounce in Apellis Pharmaceuticals Inc. offer an exitWeekly Market Summary & Safe Capital Allocation Plans - newser.com
How to build a dashboard for Apellis Pharmaceuticals Inc. stockTrade Performance Summary & Smart Swing Trading Techniques - newser.com
How interest rate cuts could boost Apellis Pharmaceuticals Inc. stock2025 Volatility Report & Safe Capital Growth Stock Tips - newser.com
Why Apellis Pharmaceuticals Inc. stock is rated strong buy2025 Price Momentum & AI Enhanced Trading Signals - newser.com
Will Apellis Pharmaceuticals Inc. (1JK) stock rise with strong economyWeekly Investment Recap & Community Verified Trade Alerts - newser.com
Will Apellis Pharmaceuticals Inc. stock maintain dividend yieldEarnings Overview Report & Daily Stock Trend Reports - newser.com
Can Apellis Pharmaceuticals Inc. (1JK) stock survive global slowdownEarnings Performance Report & Verified Short-Term Plans - newser.com
Does Apellis Pharmaceuticals Inc. (1JK) stock trade below intrinsic valueEarnings Recap Summary & Weekly High Return Stock Opportunities - newser.com
Regression analysis insights on Apellis Pharmaceuticals Inc. performanceQuarterly Profit Review & Daily Growth Stock Investment Tips - newser.com
Apellis Stock Down Despite Q3 Earnings and Revenues Beat Estimates - MSN
Apellis Pharmaceuticals Hits Day Low of $20.66 Amid Price Pressure - Markets Mojo
Brighton Jones LLC Buys Shares of 16,539 Apellis Pharmaceuticals, Inc. $APLS - MarketBeat
Apellis Pharmaceuticals Inc. recovery potential after sell off2025 Market WrapUp & Verified Momentum Stock Watchlist - newser.com
Apellis Pharmaceuticals Inc. stock prediction for this weekWeekly Trend Recap & Smart Money Movement Tracker - newser.com
Why retail investors favor Apellis Pharmaceuticals Inc. stockJuly 2025 Selloffs & Weekly High Return Stock Forecasts - newser.com
Citigroup Issues Pessimistic Forecast for Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price - MarketBeat
Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Lowered to $45.00 at TD Cowen - MarketBeat
Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Cut to $45.00 by Analysts at HC Wainwright - MarketBeat
Robert W. Baird Issues Positive Forecast for Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price - MarketBeat
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q3 2025 Earnings Call Transcript - Insider Monkey
How sentiment analysis helps forecast Apellis Pharmaceuticals Inc.July 2025 Movers & Weekly High Return Opportunities - newser.com
Jennison Associates LLC Raises Holdings in Apellis Pharmaceuticals, Inc. $APLS - MarketBeat
APLS Stock: Baird Raises Price Target to $52, Maintains Outperfo - GuruFocus
Y Intercept Hong Kong Ltd Has $2.84 Million Stock Position in Apellis Pharmaceuticals, Inc. $APLS - MarketBeat
Apellis Pharmaceuticals, Inc. $APLS Shares Sold by AlphaQuest LLC - MarketBeat
How Apellis Pharmaceuticals Inc. stock performs in weak economyJuly 2025 Breakouts & Verified Chart Pattern Signals - newser.com
Apellis Pharmaceuticals’ Earnings Call Highlights FDA Approval and Market Challenges - TipRanks
APLS: Citigroup Lowers Price Target Amidst Maintained Buy Rating - GuruFocus
Apellis Pharmaceuticals (NASDAQ:APLS) Shares Gap DownTime to Sell? - MarketBeat
Apellis Pharmaceuticals Inc Stock Analysis and ForecastDividend Cut Warnings & Free Wealth Planning Blueprints - earlytimes.in
APLS Analyst Rating Update: TD Cowen Adjusts Price Target | APLS Stock News - GuruFocus
Apellis Pharmaceuticals (NASDAQ:APLS) Releases Quarterly Earnings Results, Beats Estimates By $0.64 EPS - MarketBeat
Apellis Pharmaceuticals, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:APLS) 2025-10-31 - Seeking Alpha
Apellis Pharmaceuticals (APLS): Forecast 13% Annual Revenue Growth, Shares Trade at Deep Discount Heading Into Earnings - Yahoo Finance
1.45%
0.86%
자본화:
|
볼륨(24시간):